Major Cancer Biology Students 2019
>15. October 2019: Class of 2019 has arrived
Sahana ASOKAN (India)

© dkfz.de
Sahana had joined Major Cancer Biology @ DKFZ with a B.Tech degree in Industrial Biotechnology from Anna University, Chennai, India
Srijita BANERJEE (India)

© dkfz.de
Srijita had joined Major Cancer Biology @ DKFZ with a B.Tech degree in Biotechnology from Vellore Institute of Technology, India
Milica BEKAVAC (Serbia)

© dkfz.de
Milica had joined Major Cancer Biology @ DKFZ with a Bachelor with Honours degee in Biology from the University of Novi Sad, Serbia
Barbara BETZ (Germany)

© dkfz.de
Barbara had joined Major Cancer Biology @ DKFZ with a BSc degree in Biological Sciences from the University of Konstanz, Germany
Hannah BRIESCH (Germany)

© dkfz.de
Hannah had joined Major Cancer Biology @ DKFZ with a BSc degree in Molecular Medicine from University Ulm, Germany
Martha BUHMANN (Germany)

© dkfz.de
Martha had joined Major Cancer Biology @ DKFZ with a BSc degree in Biomedical Science (Major in Tumor Biology) from the Philipps-Universität Marburg, Germany
Iva BULJAN (Croatia)

© dkfz.de
Iva had joined Major Cancer Biology @ DKFZ with a BSc degree in Molecular Biology from the University of Zagreb, Croatia
Roman DOLL (Germany)

© dkfz.de
Roman had joined Major Cancer Biology @ DKFZ with a BSc degree in Molecular Biomedicine from the University of Bonn, Germany
Henrik ELLINGHAUS (Germany)

© dkfz.de
Henrik had joined Major Cancer Biology @ DKFZ with a BSc degree in Biology from the University of Bremen, Germany
Julie HAENLIN (France)

© dkfz.de
Maria had joined Major Cancer Biology @ DKFZ with a BSc degree in Biosciences from the Ruprecht-Karls University of Heidelberg
Nick HIRSCHMÜLLER (Germany)

© dkfz.de
University Education
2019 - present: M.Sc. Molecular Biosciences, Major Cancer Biology at the German Cancer Research Center (DKFZ) and Ruprecht-Karls-University, Heidelberg, Germany
2016-2019 Ruprecht-Karls-University Heidelberg, Bachelor of Science (B.Sc.) Molecular Biotechnology
Highest Degree: Bachelor of Science in Molecular Biotechnology
Title of Bachelor Thesis
Histopathology analysis for detecting tumor features related to invasion and prognosis – novel automated approaches
Internships/Work Experience:
02/18 – present: PEPperPRINT GmbH
04/19 – 08/19: Internship and Bachelor Thesis in the group of Prof. Dr. Magnus von Knebel Doeberitz, Heidelberg University Hospital
Scientific Interests/Future Plans
Despite decades of research, new findings about carcinogenesis and how cancerous cells manage to evade numerous cellular control mechanisms in order to grow are published on a regular basis. This reflects the immense complexity of cancer and its acute relevance in research. It is that complexity and heterogeneity, that makes it so challenging to treat and diagnose. In the past years, machine learning has opened an exciting new field in cancer research, especially regarding the diagnosis of cancer, in which I gathered firsthand experience during my bachelor thesis. I intend to continue my academic career in the field of data science and hope to one day contribute to the better understanding of cancer and thereby improving its treatment.
Contact: n.hirschmueller (at) dkfz.de
LinkedIn profile: linkedin.com/in/nick-hirschmüller-0631a8197
Ivana KARABOGDAN (Germany & Croatia)

© dkfz.de
University Education
10/2019 – present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
10/2016 – 09/2019: B.Sc. Molecular Biology at Johannes Gutenberg-University Mainz, Germany
Highest Degree: Bachelor of Science (B.Sc.) in Molecular Biology
Title of Bachelor Thesis
Analysis of the neural-specific regulation of hunchback via CRISPR/Cas9 in Drosophila melanogaster
Internships/Work Experience
05/2019 – 09/2019: Bachelor Thesis in the group of PD Dr. Joachim Urban, Institute of Developmental Biology and Neurobiology (iDN), Johannes Gutenberg-University Mainz, Germany
Scientific Interests/Future Plans
Although immense research has been done in the past years, cancer is still a feared disease and an increasing global health issue, which is responsible for millions of deaths each year. Therefore, I intend to contribute to cancer research and a better understanding of this dreadful disease. In addition, I strive to be a part in the development of safe and effective methods to prevent, diagnose and treat cancer. Among the diverse fields of cancer research, I am particularly interested in immunotherapy and virotherapy. During my Master studies at the DKFZ, I aspire to deepen my knowledge in both of these fields, gain further insight into other intriguing fields of cancer biology and gain experiences in a cutting-edge environment for research. It is my aim to pursue a PhD in biomedical research in my future.
Contact: i.karabogdan (at) dkfz.de
Chieh-Yu LEE (Taiwan)

© dkfz.de
University Education
10/2019 – present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
09/2015 – 06/2019: B.Sc. Biochemical Science and Technology at National Taiwan University, Taiwan
Highest Degree: Bachelor of Science (B.Sc.) in Biochemical Science and Technology
Title of Bachelor Thesis
Studies on CD44v6 Expression in Colon Cancer Cells from the Perspective of Alternative Splicing by Minigene Reporter Assay
Internships/Work Experience
09/2017-09/2019: Research internship and Bachelor thesis in the group of Dr. Edward Chern, Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan
07/2019: Teaching assistant in Lab course for Core Biotechnology, National Taiwan University, Taipei, Taiwan
02/2019-06/2019: Teaching assistant in Biochemistry Lab course, National Taiwan University, Taipei, Taiwan
07/2018-08/2018: Summer intern in Research and Development Division, Taiwan Liposome Company, Taipei, Taiwan
08/2016: Summer intern in OBI Pharma, Taipei, Taiwan
Scientific Interests/Future Plans
Cancer stem cell, which associated with drug resistance and easy recurrence, is the reason why cancer is hard to be completely cured. In my Bachelor thesis, I probed into the mechanism of alternative splicing in colon cancer cells which possess more stemness. This mechanism is fascinating, as the progression of cancers can be controlled by focusing on a small group of cancer stem cells within the niche. Gaining background of cancer research from my undergraduate lab work, I would like to expand my expertise to related areas, such as metastatic niche, and cancer stem cells. Moreover, my curiosity is by no means limited to these topics. I would like to learn as much as possible during my studies at the DKFZ to cultivate myself into an interdisciplinary talent.
Contact: c.lee (at) dkfz.de
LinkedIn profile
Nina LOBETO KRAMER (Spain & Switzerland)

© dkfz.de
Nina had joined Major Cancer Biology with a B.Sc. in Marine Biology from the University of Aberdeen, Scotland
Ceren ÖZERDEM (Turkey)

© dkfz.de
University Education
10/2019 - Present: M.Sc. in Molecular Biosciences - Major Cancer Biology, Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
09/2018 - 02/2019: Erasmus Programme in Biology, Radboud University, Nijmegen, the Netherlands
09/2015 - 06/2019: B.Sc. in Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
Highest Degree: Bachelor of Science in Molecular Biology and Genetics
Title of Bachelor Thesis
Characterization of a novel inhibitor for an important mitotic gene using breast cancer cell lines
Internships/Work Experience
02/2019 – 06/2019: Senior project at Bilkent University, Laboratory of Cancer Systems Biology (Asst. Prof. Ozgur Sahin), Ankara, Turkey
06/2018 – 08/2018: Summer Internship at The Rockefeller University, Laboratory of Biochemical Genetics and Metabolism (Asst. Prof Kivanc Birsoy), New York, NY, USA
02/2018 – 05/2018: Internship at Bilkent University, Laboratory of Cancer Systems Biology (Asst. Prof. Ozgur Sahin), Ankara, Turkey
07/2017 – 08/2017: Summer Internship at Izmir International Biomedicine and Genome Institute, Laboratory of Neuro-Genomics (Asst. Prof Yavuz Oktay), Izmir, Turkey
06/2016 – 07/2016: Summer Internship at Izmir International Biomedicine and Genome Institute, Laboratory of Neuro-Genomics (Asst. Prof Yavuz Oktay), Izmir, Turkey
Scientific Interests/Future Plans
I find it exciting to explore the heterogeneity of the cancer cells, how they alter their microenvironments, evade immune defense and manipulate signaling pathways, in an attempt to contribute to a cancer-free world. The idea of making even the slightest contribution in cancer therapeutics to help cancer patients excites me, because I have experienced how devastating cancer can be. That is why my ultimate goal is to pursue an academic career where I conduct my own research on personalized cancer treatment. In DKFZ, I will have the opportunity to discover different cancer-related subjects that would allow me to understand cancer biology more deeply and help me determine the certain path that I want to take in cancer research. I will also be able to extend my knowledge in various subjects such as epigenetics, stem cells and bioinformatics, which would make me an equipped scientist that I aim to become.
Contact: c.oezerdem (at) dkfz.de
LinkedIn profile: linkedin.com/in/ceren-özerdem-89b5a3133
Ferdinand POPP (Germany)

© dkfz.de
University Education
10/2019 - present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls-University Heidelberg and German Cancer Research Centre (DKFZ), Heidelberg, Germany
10/2016 - 09/2019: B.Sc. Biosciences at Ruprecht-Karls-University Heidelberg, Germany
Highest Degree: Bachelor of Science (B.Sc.) in Biosciences
Title of Bachelor Thesis
"Novel strategies for selecting engineered AAV capsids with gene therapy potential on RNA level"
Internships/Work Experience
07/2017 - present: Student assistant supervisor for the practical "Methods of Molecular Bioscience – part molecular biology" by apl. Prof. Dr. Suat Özbek, University Heidelberg, Germany
06/2018 – present: Working student in digital health software development at Gotthardt Healthgroup AG, Heidelberg, Germany
07/2019 - 09/2019: Bachelor Thesis in the research group Virus-Host Interactions of Prof. Dr. Dirk Grimm, BioQuant, Heidelberg, Germany
06/2019 – 07/2019: Research Internship at the Deep Sequencing Facility under David Ibberson, BioQuant, Heidelberg, Germany
03/2019 – 04/2019: Internship at the Digital Accelerator Division as part of the Advanced Analysis Team, QIAGEN, Hilden, Germany
Scientific Interests/Future Plans
Despite the advancement of scientific methods and treatments, cancer keeps disrupting lives. In order to contribute, I accepted the challenge to study cancer biology. Due to the complexity of this research domain, I believe that computational biology bears a massive potential for a scientific breakthrough. Breakthroughs are unpredictable like black swans, but can be harboured by diverse teams with people from different disciplines, countries, and backgrounds. Therefore I look forward to contributing to the development of novel strategies during my interdisciplinary Master´s program here at the DKFZ.
Contact: f.popp (at) dkfz.de
LinkedIn profile
Cecilia REYNERI (Italy)

© dkfz.de
University Education
10/2019 - Present: M.Sc. in Molecular Biosciences - Major Cancer Biology, Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
09/2016-07/2019: B. Sc. In Biotechnology at Università degli Studi di Torino, Torino, Italy
Highest Degree: Bachelor of Science (B. Sc.) in Biotechnology
Title of Bachelor Thesis
Tumor-derived exosomes impact on pre-metastatic niche formation via immune cell modulation
Internships/Work Experience
11/2018-5/2019: Internship at the Molecular Biotechnology Center in the group of Prof. Dr. Bussolati Benedetta, Laboratory of Renal and Vascular Pathophysiology, Torino
Scientific Interests/Future Plans
During my Bachelor studies, I was most impressed by cancer cells, being the perfect example of how both fascinating and terrible the Nature can be at the same time: cancer cells are extremely plastic, can adapt to the microenvironment, mask themselves from the immune system and avoid drugs, thus making cancer one of the main causes of death and far away to be cured. I am especially interested in the relationship of the tumor with its microenvironment and in the metabolic reprogramming of cancer and stromal cells. As a Master student at DKFZ, I aim to explore different fields of cancer research and to develop technical skills and knowledge necessary to pursue a PhD and for a future career in this field.
Contact: c.reyneri (at) dkfz.de
Deepak SAYEERAM (India)

© dkfz.de
College/University Education
08/14-05/18- B.E. Biotechnology, B.M.S College of Engineering, Bengaluru, India
10/2019- present: M.Sc. Molecular Biosciences with a Major in Cancer Biology at Ruprecht-Karls University of Heidelberg and German Cancer Research Center (DKFZ)
Highest Degree: Bachelor of Engineering in Biotechnology
Title of Bachelors Thesis
Purification and characterization of lipase from Yarrowia Lipolytica
Internships/Work experience:
05/10/18-30/6/19: Research Assistant, Research and Development Laboratory (Under Dr. Divijendra Natha Reddy), Department of Biotechnology, B.M.S College of Engineering, India
12/06/17-04/08/17: Internship at String Bio, Fermentation Department (Under Mr. Sandeep Kumar), India
06/16 and 01/17: Internship at Techniques in genetic engineering (Mr. Sreedhar Bhat), Sreedhar Bhat Laboratory, India
Scientific Interests/Future Plans
It is really impressive to know as to how the cancer cells exhibit such a diverse nature. Although they may belong to the same subtype, their functional mechanisms vary a lot. I am very keen to learn about the genetic and epigenetic aspects of cancer, as they could pave a way for discovering multiple biomarkers which could then be exploited as targets for various drugs. I believe that pursuing my Masters degree at the DKFZ, shall train me in different aspects of cancer biology and provide a strong platform for my doctoral studies and carry out independent research, so that I am capable enough to serve the cancer inflicted people.
Contact: d.sayeeram (at) dkfz.de
LinkedIn profile
Jennifer SCHIEBER (Germany)

© dkfz.de
University Education
10/19 – present: German Cancer Research Center (DKFZ) and Ruprecht-Karls-University Heidelberg, Master of Science Molecular Biosciences Major Cancer Biology, Heidelberg, Germany
03/16 – 08/19: Hochschule Furtwangen University, Bachelor of Science in Molecular and Technical Medicine, Villingen-Schwenningen, Germany
09/18 – 12/18: Edinburgh Napier University, Study semester abroad in Biomedical Sciences, Edinburgh, United Kingdom
Highest degree: Bachelor of Science in Molecular and Technical Medicine
Title of Bachelor's Thesis
Optogenetic regulation of PD-1 pathway via SHP2 trapping
Internships/Work Experience
02/19 – 07/19 Research assistant and Bachelor's thesis in the Tumor Biology group at the Natural and Medical Sciences Institute at the University of Tübingen, Germany
03/18 – 08/19 Research assistant and internship in the Tumor Biology group at the Natural and Medical Sciences Institute at the University of Tübingen, Germany (Title of report: Immunohistochemical characterization of patient-derived microtumors as a model system of human cancer)
Scientific Interests/Future Plans
The future of personalized medicine will bring great opportunities in treating patients specifically for their cancers. The idea that personalized treatment can enhance the efficacy fascinates me. During this Master's programme, I hope to expand my knowledge about different aspects of cancer biology such as its complexity and heterogeneity, the various signalling pathways and the interaction with the immune system. I want to contribute my efforts in understanding the characteristics of cancer, for example the changes in the transcriptome, proteome and metabolome. This knowledge will enable me to proceed with my academic career. In the future, I see myself taking part in this field of research during a PhD and then as a scientist in Research & Development. My goal is to apply the knowledge of my studies to evaluate personalized cancer therapies in order to fight cancer specifically and successfully.
Contact: j.schieber (at) dkfz.de
LinkedIn profile
Ann-Katrin SCHLOSSER (Germany)

© dkfz.de
University Education
10/2019 – present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls-University Heidelberg and German Cancer Research Centre (DKFZ), Heidelberg, Germany
10/2016 – 09/2019: B.Sc. Biosciences at Ruprecht-Karls-University Heidelberg, Germany
Highest Degree: Bachelor of Science (B.Sc.) in Biosciences
Title of Bachelor Thesis
Regulation of Polo-like kinase 4 via CUL4-DDB1-VprBP
Internships/Work Experience
05/2019 – 09/2019: Research Internship and Bachelor Thesis in the group of Prof. Dr. Ingrid Hoffmann, German Cancer Research Centre (DKFZ), Heidelberg, Germany
03/2019 – 04/2019: Research Internship in the group of PD Dr. Christian Thiel, Dietmar-Hopp Metabolism Centre, Centre for Child and Adolescent Medicine, University Hospital Heidelberg, Germany
04/2016 – 05/2016: Internship in the group of PD Dr. Dimo Dietrich, Institute of Pathology, University Hospital Bonn, Germany
Scientific Interests/Future Plans
The complex and diverse ways which enable cancer cells to develop their unique characteristics helping them to evade our immune system and to form a whole organized tissue fascinated me most since I started my studies in the field of biomedicine. I am excited to get the opportunity to work and learn at the German Cancer Research Centre (DKFZ) and to gain a deeper understanding of the mechanisms and molecular pathways of tumorigenesis. However, my ambition is not only to explore causes and mechanisms of carcinogenesis, but to use new insights in basic cancer research for the development of novel ways of cancer diagnosis and therapy. In future, I would love to work in the field of translational cancer research and investigate these kinds of questions while continuing towards a PhD and an academic career.
Contact: a.schlosser (at) dkfz.de
LinkedIn profile
Karolin STUMPF (Germany)

© dkfz.de
University Education
10/2019 - present: M.Sc. Molecular Biosciences, Major Cancer Biology at the German Cancer Research Center (DKFZ) and Ruprecht-Karls-University, Heidelberg, Germany
09/2018 – 12/2018: Semester abroad at the University of Victoria, Canada
10/2016 – 09/2019: B.Sc. Biomedical Science, Focus: Tumor Biology at the Philipps-University, Marburg, Germany
Highest Degree: Bachelor of Science in Biomedical Science
Title of Bachelor Thesis
Isolation and characterization of extracellular vesicles from pancreatic ductal adenocarcinoma cell lines
Internships/Work Experience
02/2019-09/2019: Bachelor Thesis in the group of Prof. Dr. Elke Pogge von Strandmann, Center for Tumor Biology and Immunology, Philipps-University, Marburg, Germany
01/2019 – 02/2019: Internship in the department of Molecular Neurooncology and Neuropathology at the Medical Research Center Seltersberg, Justus-Liebig-University, Gießen, Germany, Prof. Dr. med. Till Acker
10/2017 – 03/2018: Student assistant in the department of Mathematics at the Philipps-University, Marburg, Germany, Dr. Dorothea Strauer
01/2014 – 02/2014: Internship at the Hesse State Laboratory, Gießen, Germany
Scientific Interests/Future Plans
Being the second leading global cause of death in our aging society, cancer has become one of the most foregrounded diseases within biomedical research. My deep fascination for this research field has grown ever since I started learning about the complexity and heterogeneity of cancer as well as about the great interdisciplinarity in cancer research. Studying Cancer Biology at the DKFZ provides me with the excellent opportunity to not only improve my technical and methodological proficiency but also to deepen my knowledge about the molecular mechanisms behind and the novel treatment options against this dreadful disease. I am particularly interested in the involvement of the tumor microenvironment within tumor initiation and progression as well as in novel immunologic or virologic therapy approaches. Based on my passion for science and the ideal fundament laid by this Master's program, I would like to pursue a PhD in the future and to continue my academic career by contributing to cancer research, especially in the field of tumor immunology.
Contact: karolin.stumpf (at) dkfz.de
LinkedIn profile
David VONHÖREN (Germany)

© dkfz.de
University Education
10/2016 – 9/2019: B.Sc. Biomedical Science, Focus: Tumor Biology at the Philipps-University, Marburg, Germany
10/2019 – present: M.Sc. Molecular Biosciences, Major Cancer Biology at the German Cancer Research Center (DKFZ) and Ruprecht-Karls-University, Heidelberg, Germany
Highest Degree: Bachelor of Science (B. Sc.) in Biomedical Science
Title of Bachelor Thesis
Analysis of PRMT effects on the c-Myb dependent gene expression and establishment of a fluorescence-based PRMT activity assay
Internships/Work Experience
10/2018 – 11/2018: Internship in the group of Prof. Dr. Sven Bogdan, Institute for Physiology and Pathophysiology, Philipps-University Marburg, Germany
03/2019 – 7/2019: Student assistant with tutoring activities in the department of Medicine, Philipps-University Marburg, Germany
01/2019 – 8/2019: Bachelor Thesis in the group of Prof. Dr. Uta-Maria Bauer, Institute of Molecular Biology and Tumor Research, Philipps-University Marburg, Germany
Scientific Interests/Future Plans
Despite that huge progress has been made in the treatment of cancer, it still remains one of the leading causes of human death. Therefore, I am especially interested in the development of novel anti-cancer therapies including immunotherapy, virotherapy as well as drug design. During my Master studies at the DKFZ I would like to extend my knowledge about cancer, given that the understanding of tumorigenesis is a prerequisite for its treatment. Moreover, I wish to lay the foundation for my doctoral studies and a successful research career.
Contact: d.vonhoeren (at) dkfz.de
LinkedIn profile: linkedin.com/in/david-vonhören-740169196/
Nathalie WILKE (Germany)

© dkfz.de
University Education
10/2019-present: M.Sc. Molecular Biosciences, Major Cancer Biology at the German Cancer Research Center (DKFZ), Ruprecht-Karls-University, Heidelberg, Germany
10/2015-09/2018: B.Sc. Biology, University of Cologne, Germany
Highest Degree: Bachelor of Science in Biology
Title of Bachelor Thesis
Preclinical evaluation of arsenic compounds for the treatment of malignant diseases
Internships/Work Experience
04/2018-09/2019 Bachelor's Thesis and research assistant in the group "Experimental Oncology" of Dr. Dr. Prokop, Kliniken der Stadt Köln gGmbH, Pediatric Oncology/Hematology
08/2017-09/2017 Internship in the group "Experimental Oncology" of Dr. Dr. Prokop, Kliniken der Stadt Köln gGmbH, Pediatric Oncology/Hematology
Scientific Interests/Future Plans
Cancer is one of the greatest challenges to humankind and tremendously fascinating at the same time. With many factors contributing to cancerous diseases, it seems impossible to unravel all those mechanisms and mysteries. Constantly developing technologies and various approaches to target the different properties of cancer cells have already improved the treatment of patients in a great scale. During my master studies I desire to gain the abilities to contribute to the understanding of the complex processes associated with cancer which may also help to develop preventive measures. I am especially interested in investigating how cells evade the immune system and how specific resistances to therapies can be overcome in the field of personalized medicine. Finding new ways to successfully target cancer cells requests an interdisciplinary research environment which I am looking forward to explore at the DKFZ. By gaining insight into the multidisciplinary biomedical topics in this program I aim to broaden my methodological skills and discover which direction I want to pursue during my PhD.
Contact: n.wilke (at) dkfz.de
Lea WÖLBERT (Germany)

© dkfz.de
University Education
10/2019 - Present: M.Sc. in Molecular Biosciences - Major Cancer Biology, Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
09/17 – 06/18: Exchange year at the Department of Life Sciences, National Taiwan University, Taiwan (R.O.C.)
10/15 – 09/19: B. Sc. in Molecular Medicine at Eberhard Karls Universität Tübingen
Highest Degree: Bachelor of Science (B. Sc.) in Molecular Medicine
Title of Bachelor Thesis
Investigations on novel small molecule compounds as potential inhibitors of the anaphase promoting complex/cyclosome
Internships/Work Experience
24/08/2015 – 05/09/2015 Internship at the Max Planck Institute of Molecular Physiology, Department of Chemical Biology, Dortmund
Scientific Interests/Future Plans
Tumorigenesis is a highly complex process and influenced by a multitude of internal and external factors, resulting in heterogeneous and unique malignant entities. I am especially fascinated by how such factors can enable, accelerate or prevent carcinogenesis and the variety of the molecular pathways that are involved. Investigation on signalling mechanisms in cancer and potential causes for their dysregulation might not only help understand its development but could also have implications for prevention and therapy. Particularly this connection between individual genetic, inflammatory, environmental, and various other factors and how they influence treatment and prognosis of the developing tumour is why I first became interested in cancer biology. Therefore, I aim to pursue a Ph.D. degree in this fascinating field of research after expanding my skills and knowledge at the DKFZ.
Contact: l.woelbert (at) dkfz.de